Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (3), 455-458
- https://doi.org/10.1016/0360-3016(92)90852-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotensionBritish Journal of Cancer, 1990
- The effects of oral hydralazine on blood pressure, cardiac output and peripheral resistance with respect to dose, age and acetylator statusRadiotherapy and Oncology, 1990
- The effects of single dose oral hydralazine on blood flow through human lung tumoursRadiotherapy and Oncology, 1990
- Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1989
- Effects of Hydralazine-Induced Vasodilation on the Energy Metabolism of Murine Tumors Studied by In Vivo31P-Nuclear Magnetic Resonance Spectroscopy1JNCI Journal of the National Cancer Institute, 1988
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogsEuropean Journal of Cancer and Clinical Oncology, 1982
- Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1980